<DOC>
	<DOCNO>NCT03100708</DOCNO>
	<brief_summary>The study follow patient peritoneal carcinomatosis colorectal , ovarian , gastric , pancreatic cancer primary peritoneal tumor undergo diagnostic laparoscopy / laparotomy , PIPAC single dose repeat every 6 week . The Overall Response Rate ( ORR ) , Overall Survival ( OS ) Quality Life assess every PIPAC . Biopsies peritoneal carcinomatosis blood ( plasma serum ) collect every PIPAC intervention follow document individual success progress patient . The advice tumor board mandatory confirm indication local chemotherapy ( PIPAC ) .</brief_summary>
	<brief_title>Register Study Patients With Peritoneal Carcinomatosis Treated With PIPAC ( Pressurized Intra-peritoneal Aerosol-Chemotherapy )</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<criteria>Patient clinical pathological confirm peritoneal carcinomatosis gastric , colorectal , pancreatic , ovarian cancer primary peritoneal tumor Age &gt; 18 year sign informed consent Patient understand mean purpose study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>